Article
Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.
Clinical pharmacology and therapeutics - 1 Sept 2013
Leckband S G, Kelsoe J R, Dunnenberger H M, George A L, Tran E, Berger R, Müller D J, Whirl-Carrillo M, Caudle K E, Pirmohamed M
Abstract excerpt
Human leukocyte antigen B (HLA-B) is a gene that encodes a cell surface protein involved in presenting antigens to the immune system. The variant allele HLA-B*15:02 is associated with an increased risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in response to carbamazepine treatment. We summarize evidence from the published literature supporting this association and provide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
